Seamless phase 2/3 oncology trial design with flexible sample size determination

Zhaoyang Teng, Yuan Tian, Yi Liu, Guohui Liu

Type: Article

Publication Date: 2020-04-27

Citations: 1

DOI: https://doi.org/10.1002/sim.8543

View Publication

Locations

PubMed - View
Statistics in Medicine - View

Similar Works

Action	Title	Year	Authors
+	Optimal seamless phase 2/3 oncology trial designs based on Probability of Success (PoS)	2018	Zhaoyang Teng Liang Liang Guohui Liu Yi Liu
+	Flexible Seamless 2-in-1 Design with Sample Size Adaptation	2022	Runjia Li Liwen Wu Rachael Liu Jianchang Lin
+	An adaptive seamless Phase 2-3 design with multiple endpoints	2021	Man Jin Pingye Zhang
+	Seamless Phase 2-3 Design: A Useful Strategy to Reduce the Sample Size for Dose Optimization	2022	Jiang Liyun Ying Yuan
+	Optimal one-stage design and analysis for efficacy expansion in Phase I oncology trials	2021	Cai Wu Fang Liu Heng Zhou Xiaoqiang Wu Cong Chen
+ PDF Chat	Flexible seamless 2-in-1 design with sample size adaptation	2024	Runjia Li Liwen Wu Rachael Liu Jianchang Lin
+ PDF Chat	Evolution of global clinical trials with adaptive design	2021	Shuhang Wang Peiwen Ma Qi Lei Yuan Fang Huiyao Huang Kun Chen Ning Jiang Yuqi Yang Tang Qiyu Liang Zhang
+ PDF Chat	Overview of model-assisted design for phase I dose-finding trials in oncology	2022	Koichi Hashizume Kentaro Takeda Hiroyuki Sato Akihiro Hirakawa Takashi Sozu
+	<scp>DOD</scp>‐<scp>SSR</scp>: An Adaptive Seamless Phase <scp>II</scp>/<scp>III</scp> Design With Dose Optimization Decision and Sample Size Re‐estimation	2025	Meizi Liu Jianchang Lin Yefei Zhang Rachael Liu
+ PDF Chat	A Seamless Phase II/III Design with Dose Optimization for Oncology Drug Development	2024	Yuhan Li Yiding Zhang Gu Mi Ji Lin
+ PDF Chat	A seamless phase II/III design with dose optimization for oncology drug development	2024	Yuhan Li Yiding Zhang Gu Mi Ji Lin
+	Phase I clinical trial designs in oncology: A systematic literature review from 2020 to 2022	2024	Ning Li Xitong Zhou Donglin Yan
+	Sample Size Calculations for Phase III Trials in Oncology	2019	Koji Oba Aya Kuchiba
+	A Seamless Adaptive 2-in-1 Design Expanding a Phase 2 Trial for Treatment or Dose Selection Into a Phase 3 Trial	2021	Man Jin Pingye Zhang
+	The extension of 2-in-1 adaptive phase 2/3 designs and its application in oncology clinical trials	2020	Fan Li Jing Zhao Wen Li
+	Adaptive clinical trial designs in oncology.	2014	Yong Zang J. Jack Lee
+ PDF Chat	A Multi-Arm Two-Stage (MATS) design for proof-of-concept and dose optimization in early-phase oncology trials	2023	Zhenghao Jiang Gu Mi Lin Ji Christelle Lorenzato Yuan Ji
+	Statistical Considerations of Designs for Single-Arm Proof-of-Concept Oncology Trial with Time-to-Event Endpoint	2023	Heng Zhou Linda Sun Meihua Wang
+	Advanced Designs of Cancer Phase I and Phase II Clinical Trials	2013	Ye Cui
+	A Multi-Arm Two-Stage (MATS) Design for Proof-of-Concept and Dose Optimization in Early-Phase Oncology Trials	2023	Zhenghao Jiang Gu Mi Lin Ji Christelle Lorenzato Yuan Ji

Works That Cite This (1)

Action	Title	Year	Authors
+ PDF Chat	Master Protocols for Precision Medicine in Oncology: Overcoming Methodology of Randomized Clinical Trials	2021	Raimondo Di Liello Maria Carmela Piccirillo Laura Arenare Piera Gargiulo Clorinda Schettino Adriano Gravina Francesco Perrone

Works Cited by This (26)

Action	Title	Year	Authors
+	The asymptotic properties of nonparametric tests for comparing survival distributions	1981	David Schoenfeld
+	Group-Sequential Methods for Adaptive Seamless Phase II/III Clinical Trials	2011	Nigel Stallard
+	Combining different phases in the development of medical treatments within a single trial	1999	Péter Bauer Meinhard Kieser
+	Adaptive designs for confirmatory clinical trials	2009	Frank Bretz Franz Koenig Werner Brannath Ekkehard Glimm Martin Posch
+	Confirmatory Seamless Phase II/III Clinical Trials with Hypotheses Selection at Interim: General Concepts	2006	Frank Bretz Heinz Schmidli Franz König Amy Racine Willi Maurer
+ PDF Chat	Testing and estimation in flexible group sequential designs with adaptive treatment selection	2005	Martin Posch Franz Koenig Michael Branson Werner Brannath Cornelia Dunger‐Baldauf Péter Bauer
+	Planning and Analyzing Adaptive Group Sequential Survival Trials	2006	Gernot Wassmer
+ PDF Chat	A Comparison of Methods for Treatment Selection in Seamless Phase II/III Clinical Trials Incorporating Information on Short-Term Endpoints	2014	Cornelia Ursula Kunz Tim Friede Nick Parsons Susan Todd Nigel Stallard
+	A Seamless Phase II/III Design with Sample-Size Re-Estimation	2009	Wolfgang Bischoff Frank Miller
+	A Multiple Testing Procedure for Clinical Trials	1979	Peter C. O’Brien Thomas R. Fleming